| Shanghai SPE Chemicals Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (21) 5138-6314 | |||
![]() |
info@spechemicals.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2006 | ||||
| Capot Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8558-6718 +86 13336195806 | |||
![]() |
capotchem@gmail.com sales@capotchem.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2006 | ||||
| Hunan Astar Bio-chemicals Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (10) 5831-9740 | |||
![]() |
export02@astarchem.com | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink standard supplier since 2007 | ||||
| Manus Aktteva | India | Inquire | ||
|---|---|---|---|---|
![]() |
+91 (79) 6512-3395 | |||
![]() |
products@manusakttevabiopharma.in | |||
| Chemical distributor | ||||
| chemBlink standard supplier since 2008 | ||||
| Second Pharma Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (575) 8273-8999 +86 13484369607 | |||
![]() |
aiken1128@yahoo.com.cn | |||
| Chemical manufacturer since 2003 | ||||
| chemBlink standard supplier since 2009 | ||||
| ZHIYU Biotechnology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (512) 6279-1916 | |||
![]() |
sales@zhiyubiotech.com info@zhiyubiotech.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2008 | ||||
| chemBlink standard supplier since 2009 | ||||
| Hefei TNJ Chemical Industry Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (551) 6541-8684 | |||
![]() |
sales@tnjchem.com | |||
| Chemical manufacturer since 2001 | ||||
| chemBlink standard supplier since 2010 | ||||
| Jinan Dechenghemu Medical Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (531) 8888-3739 | |||
![]() |
dcyy@vip.sina.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| Classification | API >> Circulatory system medication >> Antihypertensive drug |
|---|---|
| Name | Valsartan |
| Synonyms | N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; CGP 48933; Diovan; Nisis; Tareg |
| Molecular Structure | ![]() |
| Molecular Formula | C24H29N5O3 |
| Molecular Weight | 435.52 |
| CAS Registry Number | 137862-53-4 |
| EC Number | 604-045-2 |
| Melting Point | 116-117 ºC |
|---|---|
| Hazard Classification | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Valsartan |